Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Catheter Precision (VTAK) EBITDA Margin (2017 - 2025)

Historic EBITDA Margin for Catheter Precision (VTAK) over the last 9 years, with Q3 2025 value amounting to 1336.73%.

  • Catheter Precision's EBITDA Margin rose 16414000.0% to 1336.73% in Q3 2025 from the same period last year, while for Sep 2025 it was 1963.42%, marking a year-over-year increase of 7405900.0%. This contributed to the annual value of 2676.9% for FY2024, which is 149970800.0% up from last year.
  • As of Q3 2025, Catheter Precision's EBITDA Margin stood at 1336.73%, which was up 16414000.0% from 2210.38% recorded in Q2 2025.
  • Over the past 5 years, Catheter Precision's EBITDA Margin peaked at 1336.73% during Q3 2025, and registered a low of 171750.0% during Q1 2021.
  • Its 5-year average for EBITDA Margin is 52716.15%, with a median of 3190.24% in 2024.
  • Its EBITDA Margin has fluctuated over the past 5 years, first plummeted by -1711830400bps in 2021, then soared by 1626291700bps in 2023.
  • Catheter Precision's EBITDA Margin (Quarter) stood at 165280.0% in 2021, then fell by -2bps to 169200.0% in 2022, then soared by 99bps to 2028.91% in 2023, then dropped by -1bps to 2047.65% in 2024, then skyrocketed by 35bps to 1336.73% in 2025.
  • Its last three reported values are 1336.73% in Q3 2025, 2210.38% for Q2 2025, and 2500.0% during Q1 2025.